title: [Lumiracoxib taken off the market in Australia. What does that mean for our patients? (interview by Dr. Judith Neumaier)].
authors.forename: Kay
authors.initials: K
authors.lastname: Brune
mesh_terms: D001315:Australia; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000401:mortality; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004008:Diclofenac / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D004335:Drug and Narcotic Control; D005858:Germany; D006801:Humans; D012307:Risk Factors
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D004008:Diclofenac; C473384:lumiracoxib